Latest News & Features
Generics
Azurity Pharmaceuticals has sued Massachusetts drug company Bionpharma, claiming that its generic of Azurity’s Epaned product infringes on a brand new patent. 19 October 2021
Americas
Apple has secured the backing of a major pharmaceutical industry trade association, as it seeks to persuade the US Court of Appeals for the Federal Circuit to revisit a case centring on a pair of health sensor patents. 19 October 2021
Generics
AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga. 19 October 2021
Big Pharma
A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology. 14 October 2021
Generics
Molina Healthcare claims that Jazz Pharmaceuticals delayed generics of its flagship narcolepsy drug Xyrem and hiked the drug prices to increase profits when it was on the verge of bankruptcy. 14 October 2021
Americas
Medical device company, Globus Medical, has filed a lawsuit against competitor Life Spine, alleging infringement of seven different patents related to spinal tech implant technology. 14 October 2021
article
The issue of how to define an antibody for patent protection purposes has been fiercely debated worldwide. Should it be defined by function, or its amino acid sequence? Takanori Abe will discuss the first antibody patent infringement lawsuit in Japan, Baxalta v Genentech & Chugai Pharmaceuticals, and the second, Amgen v Sanofi. Abe’s insights on the case are informed by his previous experience representing Baxalta in Japan. 14 October 2021
Generics
Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents. 12 October 2021
Generics
Teva Pharmaceuticals has once again petitioned the US Court of Appeals for the Federal Circuit to reconsider its decision in a dispute over generic drug labelling which held that the drugmaker infringed GlaxoSmithKline’s Coreg heart drug. 12 October 2021
Big Pharma
The English High Court has found that a challenged claim of Bayer's targeted cancer drug sorafenib is invalid due to obviousness, in a win for Israeli pharmaceutical company Teva Pharmaceuticals. 11 October 2021